GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA, according to a Business Insider report. At a price tag of about $32,500 per year, it won’t be cheap, but company representatives said in a phone call with investors this week that its cost reflects […]
Epidiolex, made by the United Kingdom-based GW Pharmaceuticals for the treatment of epilepsy, will likely become the first cannabis-derived medication approved by the FDA. A panel of 13 advisers to the FDA unanimously suggested the drug be approved, examining medical trials and gauging the risk-benefit factors to prescribing the medication. The CBD-based medication will face […]
An agreement between the state Senate and Assembly on whether to legalize medical marijuana in New York is due before midnight Monday in order to be voted on before the legislative session ends later this week. But Gov. Cuomo has outlined a series of concerns to lawmakers that must be addressed before he’ll even consider signing […]